Stakeholder Survey on the ENCePP Code of Conduct (Survey ENCePP Code of Conduct)

Study identification

• EU PAS number:
  EUPAS26545
• Study ID:
  26955
• Official title and acronym:
  Stakeholder Survey on the ENCePP Code of Conduct (Survey ENCePP Code of Conduct)
• DARWIN EU® study:
  No
• Study countries:
  Australia

  Austria

  Belgium

  Bulgaria

  Canada

  Cyprus

  Czechia

  Denmark

  Estonia

  Finland

  Germany

  Greenland

  Hungary

  Iceland

  Ireland

  Italy

  Latvia

  Liechtenstein

  Lithuania

  Luxembourg

  Malta

  Monaco

  Netherlands

  Norway

  Poland

  Portugal

  Romania

  Slovakia

  Spain

  Sweden

  Switzerland

  United Kingdom

  United States
• Study description:
  A survey of stakeholders was conducted to evaluate how potential users understand and would apply ENCePP Code of Conduct, including revisions, in practice. Five categories of stakeholders - patient and consumer organisations, healthcare professionals, pharmaceutical industry, public health body and regulators, and researchers - were invited to answer questions on five topics: usefulness, clarity, trust, study participation and redundancies in the Code in respect to other guidelines.In this report the survey and its results are described and discussed.
• Study status:
  Finalised

Research institutions and networks

Institutions

ENCePP Working Group 2 Transparency and Independence

Study timelines

Date when funding contract was signed

Planned:02/04/2018

Actual:02/04/2018

Study start date

Planned:01/06/2018

Actual:01/06/2018

Data analysis start date

Planned:16/07/2018

Actual:16/07/2018

Date of final study report

Planned:18/10/2018

Actual:18/10/2018

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable